GLP-1 Receptor Agonist Market

adamsmithimarc 4 hours ago in Business 0

The global GLP-1 receptor agonist market is surging, driven by rising type 2 diabetes and obesity rates. Valued at ~USD 53.5 billion in 2024, it’s projected to reach ~USD 156.7 billion by 2030, with a CAGR of ~17.5%. North America dominates, with semaglutide leading.

Tags :

We rely on ads to keep our content free and accessible for everyone.

To support us, kindly disable your adblocker or add our site to your whitelist.

Your support enables us to maintain and enhance your browsing experience.

Thank you for your understanding!